CWM
BPMC

Crowley Wealth Management’s Blueprint Medicines BPMC Stock Holding History

Crowley Wealth Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-200
Closed -$25.6K – 405
2025
Q2 		$25.6K Hold
200
– – 0.02% 193
2025
Q1 		$17.7K Hold
200
– – 0.02% 214
2024
Q4 		$17.4K Buy
+200
New +$18.3K 0.02% 219

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crowley Wealth Management's BPMC Position: Q3 2025 in Review

Crowley Wealth Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 200 shares — an estimated $25.6K sold.

Crowley Wealth Management first reported a position in BPMC in Q4 2024 and held it in 3 quarters. The position peaked at $25.6K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Crowley Wealth Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Crowley Wealth Management sold 200 Blueprint Medicines shares in Q3 2025, an estimated $25.6K.
  • Crowley Wealth Management first reported a position in Blueprint Medicines in Q4 2024 and held it in 3 quarters.
  • Crowley Wealth Management's Blueprint Medicines position peaked at $25.6K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Crowley Wealth Management's 13F filing for Q3 2025, filed 21 Oct 2025.